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Abstract
Aims/hypothesis The immunomodulatory capacity of adipose tissue-derived stromal cells (ASCs) is relevant for next-generation
cell therapies that aim to reverse tissue dysfunction such as that caused by diabetes. Pericyte dropout from retinal capillaries
underlies diabetic retinopathy and the subsequent aberrant angiogenesis.
Methods We investigated the pericytic function of ASCs after intravitreal injection of ASCs in mice with retinopathy of
prematurity as a model for clinical diabetic retinopathy. In addition, ASCs influence their environment by paracrine signalling.
For this, we assessed the immunomodulatory capacity of conditioned medium from cultured ASCs (ASC-Cme) on high glucose
(HG)-stimulated bovine retinal endothelial cells (BRECs).
Results ASCs augmented and stabilised retinal angiogenesis and co-localised with capillaries at a pericyte-specific position. This
indicates that cultured ASCs exert juxtacrine signalling in retinal microvessels. ASC-Cme alleviated HG-induced oxidative stress
and its subsequent upregulation of downstream targets in an NF-κB dependent fashion in cultured BRECs. Functionally,
monocyte adhesion to the monolayers of activated BRECs was also decreased by treatment with ASC-Cme and correlated with
a decline in expression of adhesion-related genes such as SELE, ICAM1 and VCAM1.
Conclusions/interpretation The ability of ASC-Cme to immunomodulate HG-challenged BRECs is related to the length of time
for which ASCs were preconditioned in HGmedium. Conditioned medium fromASCs that had been chronically exposed to HG
mediumwas able to normalise the HG-challenged BRECs to normal glucose levels. In contrast, conditioned medium fromASCs
that had been exposed to HG medium for a shorter time did not have this effect. Our results show that the manner of HG
preconditioning of ASCs dictates their immunoregulatory properties and thus the potential outcome of treatment of diabetic
retinopathy.
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NOTCH2 Neurogenic locus notch homolog protein 2
P Postnatal day
PDR Proliferative diabetic retinopathy
PGE2 Prostaglandin E2
PKC Protein kinase C
qPCR Quantitative real-time PCR
ROP Retinopathy of prematurity
ROS Reactive oxygen species
SEAP Secreted embryonic alkaline phosphatase
VEGF Vascular endothelial growth factor
Introduction
Diabetic retinopathy is the most common microvascular compli-
cation of diabetes and remains a leading cause of blindness
worldwide [1]. The prevalence of diabetic retinopathy increases
with diabetes duration and develops from non-proliferative dia-
betic retinopathy to proliferative diabetic retinopathy (PDR) and
macular oedema [2]. Hyperglycaemia in the retina activates four
main biochemical pathway-related changes: (1) polyol pathway
flux; (2) accumulation of advanced glycation end-products
(AGEs); (3) activation of protein kinase C (PKC); (4) activation
of hexosamine pathway flux [3]. Together, these molecular
changes induce formation of reactive oxygen species (ROS),
which induces impaired retinal blood flow and increased vascu-
lar permeability [4]. Retinas or vitreous from diabetic individ-
uals with PDR contain increased levels of proinflammatory
mediators including TNF-α, IL-1β [5], IL-6 [6], IL-8 [7] and
chemokine (C-C motif) ligand 2 (CCL2) [8, 9]. NF-κB is the
main transcription factor that regulates expression of proinflam-
matory genes. Activation and nuclear translocation of NF-κB
promotes forward feedback that augments the proinflammatory
state of activated cells [10]. Diabetes is related to the upregula-
tion of cyclooxygenase-2 (COX2) encoded by the
prostaglandin-endoperoxide synthase 2 gene (PTGS2), both in
macro- and microvessels [11]. In retinas of diabetic animals,
increased COX2 is followed by increased production of prosta-
glandin E2 (PGE2) [12]. At the onset of diabetic retinopathy,
pericyte dropout and the subsequent loss of retinal endothelial
cells through apoptosis causes vasoregression. This is the driving
force for the pathological angiogenesis of PDR [13]. In the nor-
mal retina, pericytes protect and regulate endothelial cell survival
and proliferation, vessel integrity and the susceptibility of vascu-
lar cells to environmental stimuli [14]. Cell therapy with adipose
tissue-derived stromal cells (ASCs) were promising in diabetic
animal models. Adipose tissue is easy to acquire and is rich in
ASCs. These ASCs are the endogenous mesenchymal stem cells
in fat and they harbour a multipotent capacity to differentiate, for
example, into adipocytes, chondrocytes and osteoblasts [15].
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Recent studies suggested a direct role for ASCs in retinal micro-
vascular support [16]. In rodent models of diabetic retinopathy,
ASCs acquired pericytic features, which dampened proliferative
angiogenesis [17, 18]. Recently, we showed that the pericytic
nature of ASCs depends on neurogenic locus notch homolog
protein 2 (NOTCH2)-based juxtacrine interaction between
ASCs and endothelial cells [18]. Moreover, ASCs may home
in on sites of inflammation [19]. The prime immunosuppressive
factors produced by mesenchymal stem cells and ASCs include
indoleamine 2,3-dioxygenase [20], PGE2 [21], nitric oxide (NO)
[22], IL-10 [23] and antioxidant enzymes such as haem
oxygenase-1 [24]. Individually or in combination, these factors
also reduce oxidative stress in target cells [25, 26]. We
hypothesised that ASCs preconditioned in high glucose (HG)
can rescue a dysfunctional retinal endothelium through suppres-
sion of the inflammation that was caused by glucose-induced
oxidative stress. The aim of this study was to investigate the
immunomodulatory paracrine function of ASCs in decreasing
the production of endothelial ROS and in the normalisation of
dysfunctional endothelial cells in diabetic retinopathy.
Methods
Cell isolation and culture Human subcutaneous adipose tissue
samples from healthy individuals (white females aged 25 to
<75 years and BMI <30 kg/m2) were obtained after liposuction
surgery (Bergman Clinics, Zwolle, the Netherlands).
Anonymously donated samples were obtained with informed
consent as approved by the ethical board of the University
Medical Center Groningen, following the guidelines for ‘waste
materials’. Lipoaspirates were enzymatically digested to obtain
the ASCs, as described in our previous study [27]. The pooled
ASCs from passages 3 to 6 were used for experiments. The
ASCs were cultured in DMEM (Lonza, Basel, Switzerland)
either with normal glucose (NG; 5 mmol/l D-glucose) or HG
(30 mmol/l D-glucose) at normoxia (21% O2). Continuous HG
maintenance of ASCs (more than three passages; ≥21 days)
was considered to be chronic HG, while short-term exposure
to HG (7 days) was considered to be acute HG. Conditioned
medium from ASCs (ASC-Cme) was collected from confluent
monolayers after culturing for more than three passages in HG-
DMEM. The percentage of FBS was reduced from 10% to 2%
(vol./vol.) for 24 h prior to collection [28].
For the co-culture of ASCs and HUVECs, single-cell sus-
pensions of HUVECs were seeded on top of confluent ASCs
monolayers or, as a control, on gelatin-coated wells at 10,000
cells/cm2 and vascular networks were allowed to form for at
least 7 days [29]. Bovine retinal endothelial cells (BRECs)
were isolated from freshly-enucleated cow eyes obtained from
the slaughterhouse as described previously [30]. First-passage
BRECs were used in all experiments. A purity of >99% was
routinely achieved in BREC culture, which was checked
microscopically, and by immunofluorescence staining of von
Willebrand factor (not shown). Confluent monolayers of
BRECs were incubated in three different groups (NG-
DMEM, HG-DMEM and ASC-Cme) for 7 days to study the
effects of each set of conditions.
Ultrastructural analyses Co-cultures were fixed in 2% (wt/vol.)
glutaraldehyde (Polysciences, Eppelheim, Germany) for 24 h.
Samples were post-fixed using osmium tetroxide (Sigma-
Aldrich, St. Louis, MO, USA)/potassium ferrocyanide
(Sigma-Aldrich) for 30 min. Next, samples were embedded in
Epon 812 (SERVA, Heidelberg, Germany) and polymerised at
37°C for 16 h followed by 56°C for 24 h. Thick sections
(0.5 μm) were stained with toluidine blue (Sigma-Aldrich).
Ultrathin sections (60 nm) were stained with uranyl-acetate
(Sigma-Aldrich) in methanol and lead citrate (Sigma-Aldrich).
Imaging was performed using a CM100 Biotwin transmission
electron microscope (FEI, Eindhoven, the Netherlands).
Animals and the retinopathy of prematurity modelAll animal
experiments in this study adhered to the association for research
in vision and ophthalmology (ARVO) Statement for the use of
animals in ophthalmic and vision research. Male C57BL/6J
mice (Charles River, Frankfurt, Germany) were housed with
free access to standard chow and water under a 12 h light-dark
rhythm. To study the effect of ASCs on hypoxia-driven angio-
genesis, newborn mice were subjected to the model of retinop-
athy of prematurity (ROP) [31]. Mice at postnatal (P) day 7
(P7) were exposed to an atmosphere of 75% oxygen with their
nursing mother for 5 days and then returned to room air at P12.
Directly after their return to room air, randomly selected mice
were intravitreally injected under anaesthesia with either 1μl of
PBS containing approximately 10,000 ASCs (passage 1) or
1 μl of PBS as a control. Eyes were enucleated under deep
anaesthesia at P13 for immunofluorescence analysis; at P13
and P19 for quantitative real-time PCR (qPCR) analysis; and
at P17 for quantification of neovascularisation. After collection,
eyes were immediately fixed in buffered formalin or stored at
−80°C for the following analysis.
Quantification of hypoxia-driven neovascularisation
Neovascularisation in retinas was assessed in paraffin sections
of P17 animals injected at P12 with ASCs or a control. To this
end, sections (6 μm) were stained with periodic acid–Schiff’s
reagent (Sigma-Aldrich). Nuclei of neovessels at the vitreous
side of the inner limiting membrane of the retinas were count-
ed as described previously [32].
Assessment of ASCs in vivo
Whole-mount retinas from P13 animals were permeabilised
with 0.5% (wt/vol.) Triton-X100 at room temperature for 1 h.
Diabetologia (2018) 61:2371–2385 2373
Overnight staining was with FITC/TRITC-labelled isolectin-
B4 (1:50; Sigma-Aldrich) at 4°C. After PBS washes, retinas
were flat-mounted in glycerol and micrographs were obtained
with a fluorescencemicroscope (Lectin-FITC/ASC-Dil red stain-
ing; Leica BMR, Bensheim, Germany) or a confocal microscope
(Lectin-TRITC/ASC-EGFP staining; Leica TCS SP2 confocal
microscope, Leica, Wetzlar, Germany). ASCs presence was re-
vealed through their pre-injection label, which was either CM-
DiI-red (ThermoFisher, Waltham,MA, USA) or enhanced green
fluorescent protein (EGFP) lentiviral tag.
Gene expression analysis Total RNAwas extracted from ASCs
andBRECs in TRIzol reagent (Life Technologies, Carlsbad, CA,
USA) following the manufacturer’s protocol. Retinas were iso-
lated from frozen eyes of ROP and control mice at P13 (n = 5)
and ROP mice at P19 in the presence of ASC injection or PBS
(n= 5). Afterwards, 1 μg of total RNA from each sample was
reverse transcribed using the First Strand cDNA Synthesis Kit
(Fermentas, Vilnius, Lithuania) according to the manufacturer’s
instructions. The cDNA equivalent of 10 ng RNAwas used for
amplification in 384-well plates in a TaqMan ABI 7900HT ther-
mal cycler (Applied Biosystems, Foster City, CA, USA) in a
final reaction volume of 10 μl containing 5 μl SYBR Green
Universal PCR Master Mix (BioRad, Hercules, CA, USA) and
6 μmol/l primer mix (forward and reverse). The cycle threshold
(Ct) values were normalised to GAPDH/ACTB as a reference
gene using theΔΔCt method [33].
Assessment of cell viability Viability was assessed using the
Apoptosis & Necrosis Kit (Promokine, Heidelberg, Germany)
as recommended in the manufacturer’s instructions. In short,
BRECs were incubated with 5 μl fluorescein-conjugated
annexin V (a marker of apoptosis) and 5 μl ethidium homo-
dimer III (at a concentration of 2 × 106 cells/ml) at room tem-
perature for 15 min. Fluorescence was recorded on a BD
FACSCalibur (BD Biosciences, Franklin Lakes, NJ, USA)
within 1 h of staining.
Quantification of ROS Cellular ROS production was deter-
mined using the dye 2′,7′-dichlorofluorescein diacetate
(DCFH-DA, Sigma-Aldrich). Two-electron oxidation of
DCFH-DA results in the formation of a fluorescent product,
dichlorofluorescein (DCF) [34]. Experimental cells were
suspended in 20 μmol/l DCFH-DA in the dark at 37°C for
15 min. The general ROS scavenger N-acetyl-L-cysteine
(NAC, 10 mmol/l, Sigma-Aldrich) and H2O2 (3 μmol/l,
Merck Millipore, Darmstadt, Germany) were used as negative
and positive controls, respectively. Samples were analysed
directly using a FACSCalibur within 15 min of staining.
Screening for immune stimulation The supernatant of HG-
stimulated BRECs cultured with or without ASC-Cme and the
control group (BRECs in NG) were collected after 7 days. To
assess the immunogenicity of these samples, THP1-XBlue-
MD2-CD14 cells (InvivoGen, Toulouse, France) were used as
described previously [35]. THP1-XBlue-MD2-CD14 cells were
plated, then each well was stimulated with samples of superna-
tants and cultured overnight at 37°C in 5% CO2.
Lipopolysaccharide (LPS, 10 μg/ml, Sigma-Aldrich) was used
as a positive control. Production of SEAP in the supernatant was
quantified using QUANTI-Blue (InvivoGen). An aliquot of
QUANTI-Blue (200 μl) was dispensed into a new flat-
bottomed 96-well plate with 20 μl of supernatant from the stim-
ulated cell-lines for 45 min at 37°C. Secreted embryonic alkaline
phosphatase (SEAP) activity, representing activation of NF-κB,
was then measured at a wavelength of 650 nm on a VersaMax
microplate reader (Molecular Devices, Biberach an der Riss,
Germany) [35].
ELISACulturemediumwas collected from different experimental
conditions. The concentrations of PGE2 and CCL2 in the medi-
um were quantified, respectively, with the Prostaglandin E2
Human ELISA Kit (ThermoFisher) and the Human CCL2/
MCP-1 DuoSet ELISA (R&D Systems, Minneapolis, MN,
USA) according to the manufacturer’s protocol. LPS (200 ng/
ml) and TNF-α (50 ng/ml, Sigma-Aldrich) were used as positive
controls. The COX2 inhibitor celecoxib (10 mmol/l, Sigma-
Aldrich) was used to inhibit PGE2 production. Results were
normalised to the number of cells in each experimental condition
and presented in pg/ml as fold change relative to their respective
experimental controls.
Monocyte adhesion assay One of the cardinal steps of inflam-
mation is the infiltration of immune cells such as monocytes
across the endothelial cell layer [36]. THP-1 monocytes were
stained using the Vybrant CFDA SE Cell Tracer Kit
(ThermoFisher) according to the manufacturer’s instructions.
Treated groups of BRECs (under HG with or without ASC-
Cme), a positive-control group (pre-incubated with medium
containing TNF-α [10 ng/ml] for 8 h) and a control group
(NG) were plated at a density of 5 × 103 cells/cm2 in standard
96-well culture plates and allowed to adhere at 37°C for 4 h.
Labelled THP-1 cells (2 × 105 cells/ml) were added to each
well. After incubation for 1 h, wells were washed to remove
non-adhered cells. Fluorescence of adherent cells was recorded
on a Varioskan spectrofluorometer (Thermo Scientific,
Waltham,MA, USA) at excitation/emission = 492/520 nm [37].
Scratch wound healing assay BRECs in three different groups
(NG, HG and ASC-Cme) were cultured until they reached
confluency. The straight, width-limited scratch was made in
all the wells, simulating a wound. The recovery of both wound
edges was recorded simultaneously using the Solamere
Nipkow confocal live cell imaging microscope (Solamere
Technology Group, Salt Lake City, UT, USA) for 30 h. The
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percentage of covered area between the edges was analysed
by ImageJ 1.8.0-172 software (imagej.nih.gov/ij/download/).
Statistical analysis Data are expressed as mean ± SEM and
relative to vehicle controls of at least three independent experi-
ments in triplicate. Statistical evaluation was performed using
unpaired t tests and ANOVA followed by Bonferroni post hoc
analysis. p values <0.05 were considered statistically significant.
Results
Ultrastructure of ASC-induced vascular networks The 0.5 μm
cross-sections showed that interconnected laminar structures
had been formed by co-cultures of endothelial cells on ASC
monolayers at day 5 and subsequent days (Fig. 1a).
Transmission electron micrographs of longitudinal sections
showed the build-up of 3D structures that comprised
endothelial-cell-derived (Fig. 1c) vessel-like structures with
a lumen (Fig. 1a–c), surrounded and tightly aligned by
ASCs (Fig. 1c). At high magnification, these vessel-like struc-
tures appeared as intermittent structures between the ASCs
(Fig. 1d). The vascular networks formed were reminiscent of
genuine vessels with respect to the slanted intercellular junc-
tions between endothelial cells (Fig. 1e, h, i). Peg-and-socket
processes [38, 39] that extended from ASC-derived pericytes
to endothelial cells had also formed (Fig. 1f, g), as well as an
extracellular matrix-based membrane between pericytes and
Fig. 1 Ultrastructure of ASC-induced vascular network. HUVECs were
seeded on confluent monolayers of ASCs. After 5 days, 0.5 μm sections
were stained with toluidine blue and analysed by light microscopy, and
60 nm sections of glutaraldehyde-fixed and plastic-embedded co-cultures
were analysed by transmission electron microscopy. (a–c) Representative
light micrographs: (a) Planar, parallel section (i.e. the top view of the
culture) showing the formation of a vascular network (arrows, endothelial
cells) demarcated by the dotted lines. Lumens (L) have formed, which are
aligned byASCs (black arrowheads) in close contact. (b) Cross section of
the lumen-containing 3D vascular structures in between (interrupted)
layers of ASCs. (c) Enlargement of a vascular structure with several
aligned ASCs (arrows, endothelial cells; black arrowheads, ASCs). (d–
i) Transmission electron micrographs of the vascular structures: (d) a
vascular structure consisting of endothelial cells (arrows) and lumen is
depicted by the dotted lines with surrounding ASCs (black arrowheads).
(e) Specific cell–cell connections with tight junctions between endothelial
cells (white arrowheads), with lumen formation on top of the ASCs. (f)
ASCs deposit extracellular matrix (black asterisks), which forms a base-
ment membrane-like structure between the endothelial cells and the
ASCs. (f, g) Peg-and-socket connections are shown by the lightning sym-
bols, and the inset in (g) shows intracellular filaments (white asterisks),
indicative of contractility, similar to smooth muscle cells, i.e. hinting at
the maturation of ASCs to pericytes. (h, i) Detailed views of the endo-
thelial cell–cell connections and basal membrane formation around the
endothelial cells, i.e. the vascular structure with connected ASCs. Scale
bar, 5 μm. Lumen (L); endothelial cells (arrows); ASCs (black arrow-
heads); endothelial cell–cell connections (white arrowheads); extracellu-
lar matrix formation (black asterisks); intracellular filaments representa-
tive for smooth muscle cell phenotype (white asterisks); peg-and-socket
connections of ASCs with endothelial cells (lightning symbols)
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endothelial cells (Fig. 1f, i). ASC-derived pericytes, i.e. those
cells in close contact with endothelial cells, had lost their
typically abundant vesicular contents compared with more
distal ASCs (Fig. 1d). These ultrastructural results indicate
that ASCs promoted formation of vascular networks by endo-
thelial cells and that ASCs had acquired a functional pericytic
phenotype in vitro (Fig. 1g).
ASCs stabilise hypoxia-driven angiogenesis but also engraft
at pericytic sites in the animal model of ROP ASCs were
injected intravitreally at P12 in the eyes of ROP-model mice
(Fig. 2a). At P13, injected ASCs were present in angiogenic
sprouts and had attached to endothelial cells of maturating cap-
illaries at a pericyte-like position (arrows, Fig. 2b, c). Further
analyses showed that dye-labelled-ASCs (green, Fig. 2d–f) had
aligned and attached to maturing intraretinal capillaries (red,
Fig. 2d–f) at pericyte-specific perivascular positions and in con-
tact with the endothelium.
Quantification of hypoxia-induced retinal neovascularisa-
tion at P17 showed that injection of ASCs in the animal models
of ROP increased neovascularisation by 54% (Fig. 2g–i; PBS
vs ASCs, 8.3 ± 0.62 vs 12.8 ± 0.96).
ASCs modulate the inflamed ROP micro-environment ROP
and control retinas (P13) were assessed by qPCR. At P13, i.e.
24 h after returning the animals from hyperoxia to ambient oxy-
gen, Angpt1 (encoding angiopoietin [ANGPT] 1) expression had
slightly decreased in ROP retinas, while Angpt2 had slightly
increased (although neither significantly) compared with the
non-ROP controls (Fig. 3a). This was accompanied by increased
expression of angiogenesis-related genes i.e. Vegfa (encoding
vascular endothelial growth factor [VEGF] A; 2.0-fold change),
Fgf2 (3.2-fold change), and Col4a1 (1.4-fold change) (Fig. 3a).
The analysis showed increased expression of proinflammatory
genes i.e. Il1b (2.0-fold change) andCcl2 (2.1-fold change) com-
pared with P13 controls. Cxcl15 (mouse orthologue of human
CXCL8) and Tnf changed non-significantly (Fig. 3a).
Comparison of ROP retinas with and without ASC intervention
showed that injection of ASCs at P12 caused a 1.5-fold increase
of Angpt1 and a 0.6-fold decrease of Angpt2, suggesting induc-
tion of vascular quiescence. Injection of ASCs into the ROP eyes
caused increased expression of inflammatory genes such as Tnf,
Cxcl15 andCcl2 by 2.2-, 1.8- and 2.5-fold, respectively. A slight
decrease was observed in the expression of proangiogenic Vegfa
and a 1.3-fold increase ofFgf2was observed in ROP at P19 with
ASCs, compared with the control ROP at P19 without ASCs
(Fig. 3b). No differences in the expression of Pdgfb, Col4a1
and Il1b were detected.
Chronic or acute exposure to HG influences ASC gene expres-
sion The expression of 36 relevant genes was measured in ASCs
after acute exposure to HG (i.e. maintained in NG medium,
followed by 7 days in HG medium) or chronic exposure to HG
(i.e. always maintained in HG medium and for more than
21 days). Data are presented as the fold change compared with
(chronic) maintenance in NG medium (Fig. 4a, b). The acute
exposure of ASCs toHG upregulated the proinflammatory genes
TNF (1.8-fold change), IL1A (6.0-fold change), IL6 (4.5-fold
change), CCL2 (4.3-fold change) and CXCL8 (6.0-fold change);
as well as the proangiogenic genes VEGFA (4.8-fold change),
ANGPT2 (1.8-fold change) and MMP1 (4.2-fold change).
Expression of the angiopoietin receptors TIE1 and TEK (also
known as TIE2) was downregulated (0.52-fold and 0.47-fold
change, respectively). The glucose transporter SLC2A1
(encodingGLUT1)was upregulated 2.5-fold. Interestingly, acute
HG exposure induced a 4.9-fold change in the mesenchymal
pericyte marker RGS5, while expression of other mesenchymal
markers such as ACTA1, TAGLN and PDGFRB changed only
marginally. Endothelial marker PECAM1 was also upregulated
(1.3-fold change). The expression of two immunoregulatory
genes, PTGS2 (encoding COX2) and IDO1, were upregulated
(3.4-fold and 3.6-fold change, respectively). The expression of
all genes in ASCs was similar upon culture under chronic HG
and chronic NG conditions, which indicated that ASCs adapt to
different glucose concentrations in the culture medium during
long-term culture. The inflammatory response after acute expo-
sure to HG resulted in an increased release of PGE2 (11.0-fold
change) and CCL2 (1.6-fold change) by ASCs, compared with
chronic exposure to HG (Fig. 4c, d). Interestingly, chronic expo-
sure to HG medium slightly decreased PGE2 secretion (0.3-fold
change) and secretion of CCL2 (0.8-fold change) compared with
controls maintained in NG. LPS and TNF-α both induced the
secretion of PGE2 and CCL2, while celecoxib inhibited the pro-
duction of PGE2 completely and had less effect on secretion of
CCL2 in acute-HG-stimulated ASCs.
The antioxidant role of ASC-Cme abrogates NF-κB activation
and promotes cell viability of BRECs Culture of BRECs under
HG conditions for 7 days induced cell death (viability ∼88% vs
94.6% for HG vs NG, Fig. 5a). Apoptosis was increased
(annexin V-positive cells ∼11.2% vs 4.6% for HG vs NG,
Fig. 5b), while necrosis had also increased (ethidium homodi-
mer lll-positive cells ∼0.73% vs 0.45% for HG vs NG, Fig. 5c).
Simultaneous treatment of HG-stimulated BRECs with ASC-
Cme (i.e. conditioned medium fromASCs chronically cultured
in HG medium) normalised viability (∼93.9% vs 88% for
ASC-Cme vs HG, Fig. 5a) and suppressed apoptosis (∼4.8%
vs 11.2% for ASC-Cme vs HG, Fig. 5b) and necrosis (∼0.25%
vs 0.73% for ASC-Cme vs HG, Fig. 5c) of the BRECs.
Exposure of BRECs to HG increased intracellular ROS
production (4.6-fold change compared with NG controls,
Fig. 5e), while ASC-Cme abrogated this (0.4-fold change,
Fig. 5e). This was comparable to the NAC effect on HG-
induced BRECs (0.25-fold change, Fig. 5e).
The monocytic NF-κB reporter (SEAP) cell line THP1-
XBlue-MD2-CD14 was used to assess the proinflammatory
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capacity of conditioned medium obtained from BRECs that
were co-treated with HG and ASC-Cme. The strongest
activation of NF-κB occurred after stimulation with LPS
(29.0-fold change, Fig. 5f), while neither NG nor HGmedium
Fig. 2 ASCs enhance hypoxia-driven angiogenesis in the ROP mouse
model. (a) Scheme of the ROP model. Mouse pups were exposed to
hyperoxia (75%O2) from P7 to P12 and subsequently transferred to room
air (21% O2). This causes hypoxia at room air that results in extensive
retinal neovascularisation at P17. ASCs were injected into the vitreous at
P12 to evaluate their influence on hypoxia-driven neovascularisation. (b,
c) Representative micrographs of CM-DiI-labelled ASCs (red, white ar-
rows) co-localising with the endothelial layer (lectin, green); magnifica-
tion × 20. (d–f) Micrographs of EGFP-tagged ASCs (green) co-localising
with the endothelial layer (lectin, red) in the pericytic position. The scale
bars in (d–f) are 100 μm, 25 μm and 15 μm, respectively. (g, h)
Histological analysis of the effects of ASC injection on hypoxia-induced
retinal neovascularisation; magnification × 20. Neovascularisation was
assessed histologically by counting the endothelial cell nuclei anterior
to the inner limiting membrane. (g) Histological features of retinal neo-
vascularisation in the control group. (h) Histological features of retinal
neovascularisation in ASC-injected mice. Intravitreal injection of ASCs
in the ROP mouse model increased the number of neovascular tufts ex-
tending into the vitreous (black arrows). (i) Hypoxia-driven neovascular-
isation in the retinas was enhanced by 54% in animals injected with ASCs
(PBS vs ASC, 8.3 ± 0.62 vs 12.8 ± 0.96). The graph shows the mean
number of neovascularisation nuclei per section per animal, ***p <
0.001. GCL, ganglion cell layer; ILM, inner limiting membrane; INL,
inner nuclear layer; neovascul., neovascularised; ONL, outer nuclear
layer
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(DMEM) had any influence. Compared with NG controls, the
activation of monocyte-expressed NF-κB increased (1.4-fold
change) upon exposure to conditioned medium from HG-
stimulated BRECs. In contrast, NF-κB activation was normal-
ised to NG control levels (0.6-fold change) by conditioned
medium from BRECs that were HG induced and simulta-
neously treated with ASC-Cme.
ASC-Cme downregulates principal inflammatory factors in
HG-challenged BRECs HG stimulation of BRECs for 7 days
upregulated the gene expression of the relevant proinflamma-
tory genes TNF, IL1B, IL1A, IL6, CXCL8 and CCL2, as well
as leucocyte adhesion-related genes SELE, ICAM1 and
VCAM1. In addition, the proangiogenic genes ANGPT1,
ANGPT2, VEGFA, VEGFB and PDGFB, and the endothelial
NO synthases, NOS2 and NOS3, were upregulated, as well as
PTGS2. The upregulation of these genes was normalised to
NG control level in ASC-Cme-treated HG-challenged
BRECs. Only KLF4 did not change after HG challenge of
BRECs. Interestingly, expression of both KLF4 and NOS2
were upregulated in ASC-Cme-treated HG-challenged
BRECs. The expression of ANGPT1, a vessel quiescence-
associated factor, remained increased upon ASC-Cme treat-
ment of HG-challenged BRECs (Fig. 6a–r).
As expected, the proinflammatory condition of HG-
challenged BRECs (Fig. 6a–r) also increased their adhesiveness
to THP-1 monocytes (2.4-fold change, Fig. 7a), while treatment
with ASC-Cme normalised monocytic adhesion to NG levels
(0.6-fold change). Treatment of BRECs with TNF-α promoted
the strongest adhesion of monocytes (4.5-fold change, Fig. 7a).
Wound closure of BRECs cultured in NG medium, after
HG challenge or treatment with ASC-Cme during HG chal-
lenge, was similar over a measurement period of 30 h, after
which time full closure occurred (Fig. 7b).
Fig. 3 ASCs modulate the ROP micro-environment. Gene expression
analyses normalised to Gapdh of (a) dissected ROP retinas at P13 (grey
bars) compared with the control retinas at P13 (white bars). The expres-
sion levels of Vegfa, Fgf2, and Col4a1 were increased. In addition, an
inflammatory response was induced, as measured by increased expres-
sion of Il1b and Ccl2. (b) To assess the ASC-guided changes to the ROP
micro-environment at P19, gene expression in ROP retinas of eyes with
ASC injection (grey bars) were compared with controls (white bars). We
observed increased expression ofAngpt1 and Fgf2, and decreased expres-
sion ofAngpt2 in ROP retinas of eyes with ASC injection. The expression
of Vegfa, Pdgfb and Col4a1 was similar to controls. The inflammatory
response wasmodulated by normalised Il1b expression, while the expres-
sion of Tnf, Cxcl15 and Ccl2 was increased. *p < 0.05, **p < 0.01 vs
control retinas. Graphs show the means ± SEM from retinas of five ani-
mals in each group; experiments were performed in triplicate
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Fig. 4 Anti-inflammatory and anti-apoptotic effects of ASCs depend on
chronic HG preconditioning. (a, b) Expression of 36 genes, normalised to
ACTB, in ASCs after acute exposure to HG (7 days) or chronic HG (more
than 21 days maintenance in HG) compared with NG-exposed controls.
Grey bars, acute HG exposure; white bars, chronic HG exposure. Graphs
represent data ± SEM from n = 4 independent experiments. *p < 0.05,
**p < 0.01, ***p < 0.001 vs NG-exposed control. (c, d) The inflammato-
ry response in HG conditions was induced in ASCs and measured by
ELISA to detect PGE2 and CCL2 in ASC-Cme. LPS and TNF-α were
used as positive-stimulated controls. Celecoxib (10 mmol/l) was used as
an inhibitor of COX2 in acute-HG-treated ASCs. Graphs show mean ±
SEM from n = 5 independent experiments. *p < 0.05, **p < 0.01, ***p <
0.001 vs NG control; ††p < 0.01, †††p < 0.001 vs chronic HG. Genes
encode the following proteins: TNF, tumour necrosis factor; IL1B, IL-
1β; IL1A, IL-1α; IL6, IL-6; CXCL8, C-X-C motif chemokine ligand 8
(also known as IL-8); CCL2, chemokine (C-C motif) ligand 2; PTGS2,
prostaglandin-endoperoxide synthase 2; CXCL12, C-X-C motif
chemokine 12; NFKB1 , NF-κB subunit 1; MMP1 , matr ix
metallopeptidase 1; ICAM1, intercellular adhesion molecule 1; IDO1,
indoleamine 2,3-dioxygenase 1; IL1R1, IL-1 receptor type 1; IL1RN,
IL-1 receptor antagonist; IL10RA, IL-10 receptor subunit α; IL10RB,
IL-10 receptor subunitβ; SLC2A1, solute carrier family 2 member 1 (also
known as GLUT1); SLC2A4, solute carrier family 2 member 4 (also
known as GLUT4); VEGFA, vascular endothelial growth factor A;
KDR, kinase insert domain receptor/VEGF receptor 2; TGFB1, TGF-
β1; FGF2, fibroblast growth factor 2; IGF, IGF; ANGPT1, angiopoietin
1; ANGPT2, angiopoietin 2; TIE1, tyrosine kinase with immunoglobulin
like and EGF like domains 1; TEK, TEK receptor tyrosine kinase (also
known as Tie2); PDGFRB, platelet derived growth factor receptor β;
RGS5, regulator of G-protein signalling 5; TAGLN, transgelin; ACTA1,
actin α1; PECAM1, platelet/endothelial cell adhesion molecule 1 (skele-
tal muscle); CNN1, calponin 1; MCAM, melanoma cell adhesion mole-
cule (also known as CD146); DES, desmin; THY1, Thy-1 cell surface
antigen (also known as CD90)
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Discussion
The main results of our studies are that human ASCs stim-
ulate retinal angiogenesis in ROP mice via acquisition of a
pericytic position and function. This was confirmed by ul-
trastructural analyses showing that in vitro ASCs promote
vascular network formation of endothelial cells and stabilise
these networks via a pericytic function. Extracellular matrix
Fig. 5 The antioxidant role of ASC-Cme, combined with declining NF-
κB activation, promotes cell viability of HG-challenged BRECs. (a)
ASC-Cme promotes BREC viability following HG-induced apoptosis
(viability ∼88% vs 94.6%, HG vs NG; 88% vs 93.9%, HG vs Cme).
(b) HG-induced apoptosis was normalised by ASC-Cme (annexin V-pos-
itive cells ∼11.2% vs 4.6%, HG vs NG; 11.2% vs 4.8%, HG vs Cme). (c)
Necrosis (ethidium [ET] homodimer lll-positive cells ∼0.73% vs 0.45%,
HG vs NG; 0.73% vs 0.25% HG vs Cme). (a–c) LPS was used as a
positive control. (d) The histogram shows the representative increase of
fluorescence intensity (by DCF) after exposure to HG or H2O2 control
compared with NG or ASC-Cme and NAC treatment. (e) HG induces
ROS in BRECs. Total cellular ROS production was measured by DCF.
ASC-Cme suppressed ROS production in the presence of HG, compared
with HG alone. The ROS inhibitor NAC and H2O2 were used as negative
and positive controls, respectively. (f) NF-κB activation by conditioned
BREC medium in THP1-XBlue-MD2-CD14 cells, and mediated by
ASC-Cme. NF-κB activationwas significantly higher in cells treated with
BREC conditioned medium under HG conditions (BREC under HG),
compared with unstimulated control. This response was almost absent
when cells were treated with ASC-Cme alongside BREC conditioned
medium under HG conditions (BREC under Cme). LPS was used as a
positive control for THP1-XBlue-MD2-CD14 cells and induced NF-κB
activation. RPMI-1640 medium, NG-DMEM andHG-DMEMwere used
as controls, which had no effect on activation of THP1-XBlue-MD2-
CD14 cells. Absorbance values were plotted to express NF-κB activation
with arbitrary units. *p < 0.05, **p < 0.01, ***p < 0.001 vs NG control;
†p < 0.05, ††p < 0.01, †††p < 0.001 vs HG. Values are mean ± SEM (n =
4 in a–c, f and n = 5 in e). Cme, ASC-Cme
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was deposited between ASC-derived pericytes and endothe-
lial cells in vitro, while typical peg-and-socket connections
were also formed [38, 39]. Acute exposure of ASCs to HG
caused a proinflammatory and proangiogenic activation
compared with ASCs that were propagated chronically in
HG. In fact, conditioned medium from ASCs that had been
chronically exposed to HG reduced ROS and proinflamma-
tory activation of BRECs challenged with HG. Activated
Fig. 6 ASC-Cme downmodulates the main inflammatory genes in HG-
challenged BRECs, compared with NG-treated controls. (a–r) HG up-
regulated the expression of the main genes related to inflammation (ex-
cluding KLF4, n). The upregulation of TNF, IL1B, IL1A, IL6, CXCL8,
VCAM1, SELE, ICAM1, VEGFA, VEGFB, PDGFB, CCL2, PTGS2, and
NOS3 was significantly modulated (reduced) by ASC-Cme. ASC-Cme
upregulated the gene expression of ANGPT1, KLF4 and NOS2. Values
are mean ± SEM (n = 6). *p < 0.05, **p < 0.01, ***p < 0.001 vs NG
control; †p < 0.05, ††p < 0.01 vs HG
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genes were reduced to normal expression levels, while en-
dothelial protective genes such as KLF4 were upregulated.
The immunomodulatory properties of ASCs [40–42] may
vary upon passaging in culture [41]. Early passages of
ASCs express markers, e.g. ligands that stimulate cells of
the adaptive immune system such as MHCII, CD80 and
CD86, which are lost upon passaging [41, 43]. Our results
show that ASC injection into ROP mice, a model of path-
ological angiogenesis in PDR [44], led to an increased
expression of inflammatory genes such as Tnf, Cxcl15
and Ccl2, which might relate to the early passaging of
ASCs. The balance of ANGPT1 and ANGPT2 and the ex-
pression of VEGFA are among the most important regula-
tors of vascular development, maturation and maintenance
[45]. Reduced expression of pericyte-derived ANGPT1, and
concomitant upregulation of its antagonist ANGPT2 and
increased VEGFA levels induce pericyte dropout, vessel
destabilisation and sprouting angiogenesis [46]. In ROP
retinas of ASC-treated mice, expression of Angpt1 and
Fgf2 were increased, while levels of Angpt2 and Vegfa
were reduced. Injected ASCs adhered to neovessels at a
pericytic position. This corroborates the role of NOTCH2
in the juxtracrine function of ASCs [18]. Earlier work from
our group showed that under acute HG culturing, ASCs
largely maintain their pericytic role as an endothelial
supporting cell, despite an upregulated ROS production ac-
companied by increased apoptosis in ASCs [29].
In general, most papers use DMEM as constitutive cul-
ture medium to propagate ASCs. This medium contains
25 mmol/l D-glucose, which is, in fact, similar to
hyperglycaemic conditions in vivo. A main finding of
our study was that chronic exposure of ASCs to HG me-
dium normalised gene expression to levels seen under NG
conditions. Interestingly, in comparison to chronic propa-
gation in HG, ASCs that were shifted from NG-DMEM to
HG-DMEM for 7 days had upregulated gene expression
of proinflammatory cytokines and chemokines, but also of
proangiogenic factors. Moreover, secretion of PGE2 and
CCL2 were also strongly increased. COX2 is responsible
for the diabetes-induced retinal PGE2 production, and in-
hibition of COX2 inhibited the diabetes-induced upregula-
tion of retinal VEGF, which links COX2 expression to
angiogenesis in diabetic retinopathy [12, 47, 48]. PGE2
activates the extracellular signal-regulated kinases 1 and
2 (ERK1/2) and thus promotes angiogenesis through en-
dothelial upregulation of the secretion of e.g. VEGF,
chemokines and activation of cell cycle genes [49, 50].
Thus, the acute HG exposure of ASCs likely renders
these cells in a proangiogenic state. Their upregulated
expression of proinflammatory genes likely also activates
endothelial cells. Yet the exposure of retinal endothelial
cells to HG alone activated NF-κB and increased expres-
sion of downstream IL1B, VEGFA, TNF and ICAM1 to
name a few of the upregulated main proinflammatory
genes. ASC-Cme suppressed these proinflammatory
genes such as PTGS2 in BRECs plus VEGFA as a
proangiogenic gene. Acute HG exposure of ASCs would
induce endothelial dysfunction rather than counteract it.
However, the continuous propagation of ASCs in HG
medium not only suppresses their proinflammatory sta-
tus, but also augments their capacity to normalise endo-
thelial cell function. This was corroborated in HG-
activated BRECs by the suppression, by ASC-Cme, of
ROS production, the reduction of monocyte adhesion
and improved cell survival (Fig. 8). Part of the immuno-
suppression resides in the suppression of endothelial
ROS production by ASC-secreted factors, because ROS
functions, via activation of TAK1, as an activator of
NF-κB. Taken together, our results show that HG pre-
conditioning of ASCs potentially improves their thera-
peutic efficacy as compared with short-term exposure to
environmental conditions such as HG.
Fig. 7 (a) THP-1 cell adhesion to BRECs exposed to HG, with and
without ASC-Cme. The intensity of fluorescence of adherent THP-1 cells
(mean ± SEM, n = 3, fold change of NG-treated control) in resting or
activated BRECs was measured. A significant decrease in adhered
THP-1 cells occurred after treatment of HG-challenged BRECs with
ASC-Cme, compared with HG treatment alone. (b) Scratch wound
healing assay to study interaction in the BREC monolayer under NG,
HG and ASC-Cme conditions. The percentage of covered area between
the wound edges was analysed. The percentage signifies the remaining
gap size 30 h after making the scratches, compared with the initial gap
size. The gap width decreased in a similar pattern in all three groups (NG,
closed circles; HG, open circles; ASC-Cme, open diamond) and was not
significantly delayed in HG conditions. Values are mean ± SEM. **p <
0.01, ***p < 0.001 vs NG control; †p < 0.05 vs HG
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Fig. 8 Therapeutic actions of ASCs in the normalisation of HG-chal-
lenged BRECs: a roadmap to the treatment of diabetic retinopathy. (a)
BRECS under HG conditions and (b) with the addition of ASC-Cme.
This model was corroborated in HG-activated BRECs by the suppression
of ROS production by ASC-Cme, together with a reduction in monocyte
adhesion and improved cell survival. ASCs preconditioned in HG can
rescue dysfunctional retinal endothelium through suppression of the in-
flammatory and proangiogenic genes induced by glucose-induced oxida-
tive stress, and can stabilise their vascular networks via pericytic function.
EC, endothelial cell; ICAM1, intercellular adhesion molecule 1; PS,
phosphatidylserine; SELE, selectin E; VCAM1, vascular cell adhesion
molecule
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